Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-22T16:20:28.064Z Has data issue: false hasContentIssue false
  • English
  • Français

The Origins of Analgesic Nephropathy

Published online by Cambridge University Press:  29 January 2018

Robin M. Murray
Robin M. Murray*
Affiliation:
University Department of Medicine, Western Infimary, Glasgow; now Registrar, The Maudsley Hospital, Denmark Hill, London SE5 8AZ
Get access Rights & Permissions [Opens in a new window]

Extract

The association between renal papillary necrosis and prolonged ingestion of compound analgesics containing aspirin and phenacetin, has been widely reported (5, 6, 11, 13, 17, 19, 20, 24, 42). Although formerly thought to occur mainly in Switzerland, Scandinavia and Australia, analgesic nephropathy is now being increasingly reported in Britain (3, 26, 36), and in particular in Western Scotland (33). In the past seven years over 100 cases have been seen in the renal unit of the Western Infirmary, Glasgow, and, of these 42 have died in uraemia.

Type
Papers
Information
The British Journal of Psychiatry , Volume 123 , Issue 572 , July 1973 , pp. 99 - 106
Copyright
Copyright © Royal College of Psychiatrists, 1973 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Abrahams, M. J., Armstrong, J., and Whitlock, F. A. (1970). ‘Drug dependence in Brisbane.’ Medical Journal of Australia, 2, 397–404.CrossRefGoogle ScholarPubMed
2 Battergay, R. (1958). ‘Individuelle und soziale Ursachen.’ Schweizerische Medizinische Wochenschrift, 88, 89–92.Google Scholar
3 Bell, D., Kerr, D. N. S., Swtnney, J., and Yeates, W. K. (1969). ‘Analgesic nephropathy.’ British Medical Journal, iii, 378–82.Google Scholar
4 Cass, L. J., and Frederick, W. S. (1962). Current Therapeutic Research, 4, 583.Google Scholar
5 Clarkson, A. J. R., and Lawrence, J. R. (1970). ‘The clinical features of analgesic nephropathy’, in Renal Infection and Renal Scarring (ed. Kincaid-Smith, P. and Fairley, K. F.), p. 375. Melbourne.Google Scholar
6 Dawborn, J. K., Fairley, K. F., Kincaid-Smith, P., and King, W. E. (1966). ‘The association of peptic ulceration, chronic renal failure and analgesic abuse.’ Quarterly Journal of Medicine, 35, 69–83.Google Scholar
7 De Kornfield, T. J., Lasagna, L., and Frazier, T. M. (1962). ‘A comparative study of 5 proprietary analgesics.’ Journal of the American Medical Association, 182, 1315–18.Google Scholar
8 Driesbach, R. H., and Pfeiffer, C. (1943). ‘Caffeine-withdrawal headache.’ Journal of Laboratory and Clinical Medicine, 28, 1212–19.Google Scholar
9 Eade, N. R., and Lasagna, L. (1967). ‘A comparison of acetophenetidin and acetaminophen.’ Journal of Pharmacology and Experimental Therapeutics, 155, 155, 301–8.Google ScholarPubMed
10 Eddy, N. B., Friebel, H., Hahn, K. J., and Halbach, H. (1970). Codeine and its Alternatives for Pain and Cough Relief. 1. Geneva: World Health Organization.Google Scholar
11 Fellner, S. K., and Tuttle, E. P. (1969). ‘The clinical syndrome of analgesic abuse.’ Archives of Internal Medicine, 124, 379–82.CrossRefGoogle ScholarPubMed
12 Frithz, G. (1967). ‘Phenacetin nephropathy in a mother and daughter.’ Acta Medica Scandinavica, 181, 529–33.CrossRefGoogle Scholar
13 Gault, M. H., Rudwal, T. C., Engles, W., and Dossetor, B. (1968). ‘Syndrome associated with the abuse of analgesics.’ Annals of Internal Medicine, 68, 906–23.Google ScholarPubMed
14 Gault, M. H., Rudwal, M. H., Rudwal, T. C., and Redmond, N. I. (1968). ‘Analgesic habits of 500 veterans.’ Canadian Medical Association Journal, 98, 619–26.Google ScholarPubMed
15 Gillies, M. A., and Skyring, A. (1968). ‘Gastric ulcer, duodenal ulcer, and gastric carcinoma: a case-control study of certain social and environmental factors.’ Medical Journal of Australia, ii, 1132–6.Google Scholar
16 Goodman, L. S., and Gilman, A. (1970). The Pharmacological Basis of Therapeutics, 4th edition. London: Macmillan.Google Scholar
17 Grimlund, K. (1963). ‘Renal papillary necrosis at a Swedish factory.’ Acta Medica Scandinavica, 174, Suppl. 405, 1.CrossRefGoogle Scholar
18 Gsell, O., Kielholz, P., and Hegg, J. J. (1961). ‘Phenacetinabus.’ Schweizerische Medizinische Wochenschrift, 91, 1529–31.Google Scholar
19 Gsell, O., Dubach, U. C., and Raillard-Peucker, U. (1968). ‘Phenacetinabusus und Nierenleiden’, Deutsche Medizinische Wochenschrift, 93, 101.CrossRefGoogle Scholar
20 Harvald, B. (1963). ‘Renal papillary necrosis. A clinical survey of 66 cases.’ American Journal of Medicine, 35, 69–63.Google Scholar
21 Jeffcoate, T. N. A. (1962). The Principles of Gynaecology. London: Butterworth.Google Scholar
22 Jeffreys, M., Brotherston, J. H. F., and Cartwright, A. (1960). ‘Consumption of medicines on a working class housing estate.’ British Journal of Preventive and Social Medicine, 14, 64–76.Google Scholar
23 Kielholz, P. (1970). ‘Present problems of drug dependence in Switzerland.’ Bulletin on Narcotics, 22, 2, 1–6.Google Scholar
24 Kincaid-Smith, P. (1969). ‘Analgesic nephropathy—a common cause of renal disease in Australia.’ Medical Journal of Australia, ii, 1131–5.Google Scholar
25 Koch, B., Irvine, A. H., McIver, J. R., and Liepa, E. (1968). ‘Renal papillary necrosis and abuse of analgesics.’ Canadian Medical Association Journal, 98, 8–15.Google ScholarPubMed
26 Koutsainmanis, K. G., and de Wardener, H. E. (1970). ‘Phenacetin nephropathy, with particular reference to the effect of surgery.’ British Medical Journal, iv, 131–4.Google Scholar
27 Krumholz, W. V., Sheppard, B. A., and Merlis, S. (1965). ‘Studies with acetylsalicylic acid. II.’ Clinical Pharmacology and Therapeutics, 6, 359–61.CrossRefGoogle ScholarPubMed
28 Le Barre, (1964). ‘À propos des propriétés toxicomanogênes des associations codéine-phénacétine.’ Thérapie, 19, 1047.Google Scholar
29 Larsen, K., and Moller, C. E. (1959). ‘A renal lesion caused by abuse of phenacetin.’ Acta Medica Scandinavica, 164, 53–71.CrossRefGoogle ScholarPubMed
30 Lasagna, L. (1965). ‘Drug interaction in the field of analgesic drugs.’ Proceedings of the Royal Society of Medicine, 58, 978–83.Google ScholarPubMed
31 Murray, R. M., Timbury, G. C., and Linton, A. L. (1970). ‘Analgesic abuse in psychiatric patients.’ Lancet, i, 1303–5.Google Scholar
32 Murray, R. M., (1972). ‘Persistent analgesic abuse in analgesic nephropathy.’ Journal of Psychosomatic Research, 16, 57–72.CrossRefGoogle ScholarPubMed
33 Murray, R. M., Lawson, D. H., and Linton, A. L. (1971). ‘Analgesic nephropathy; clinical syndrome and prognosis.’ British Medical Journal, i, 479–482.CrossRefGoogle Scholar
34 National Opinion Polls (1970). Omnibus Survey on Powders and Tablets. Google Scholar
35 Patel, A. R. (1972) Lancet, ii, 1099.CrossRefGoogle Scholar
36 Prescott, L. F. (1966). ‘Analgesic abuse and renal, disease in North-East Scotland.’ Lancet, ii 1143–5.Google Scholar
37 Prescott, L. F. Steel, R. F., and Ferrier, W. R. (1970). ‘The effects of particle size on absorption of phenacetin in man.’ Clinical Pharmacology and Therapeutics, 11, 496–504.CrossRefGoogle ScholarPubMed
38 Purnell, J., and Burry, A. F. (1967). ‘Analgesic consumption in a country town.’ Medical Journal of Australia, ii, 389–91.Google Scholar
39 Registrar General for Scotland. Personal communication based on 1961 and 1966 Census.Google Scholar
40 Schweinoruber, R. von (1955). Schweizerische Medizinische Wochenschrift, 85, 1162.Google Scholar
41 Shelley, J. H. (1967). ‘Phenacetin through the looking glass.’ Clinical Pharmacology and Therapeutics, 8, 427–71.CrossRefGoogle ScholarPubMed
42 Spuhler, O., and Zollinger, H. U. (1953). ‘Die chronische-interstitielle Nephritis.’ Zeitschrift fur Klinische Medizin, 151, 1.Google ScholarPubMed
43 Urban, H. (1964). ‘Schaden am Zentralnervensystem durch Missbrauch phenacetinhaltingen Mischpräparate.’ Deutsche Medizinische Wochenschrift, 89, 223–9.CrossRefGoogle Scholar
44 Wilson, C. W. M. (1965). ‘Pharmacological aspects of addiction to morphine and other drugs.’ Proceedings of the Royal Society of Medicine, 58, 405–8.Google ScholarPubMed
45 Whitlock, F. A., and Lowrey, J. A. (1967). ‘Drug dependence in psychiatric patients.’ Medical Journal of Australia, i, 1157–66.Google Scholar
46 Wolf, H. G., Hardy, J. D., and Goodell, H. (1941). ‘Measurement of the effect on the pain threshold of various analgesics.’ Journal of Clinical Investigation, 20, 63–80.Google Scholar
47 World Health Organization (1969). Expert Committee on Drug Dependence, 16th Report. Technical Report Series, No. 407.Google Scholar
48 World Health Organization (1964). Expert Committee on Drug Dependence, 13th Report. Technical Report Series, No. 273.Google Scholar
49 World Health Organization (1965). Expert Committee on Drug Dependence, 14th Report. Technical Report Series, No. 312.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.